Trial intelligence / Profile preview

Zoledronic acid for arterial calcification and arterial stiffness in female twins

2010-019656-41Phase 4Terminated

Sponsor
King's College London
Start
Jul 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in arterial calcification and arteriosclerosis comparing Zoledronic acid with Placebo (2 arms). Primary endpoint: Reduction in arterial stiffness over time. Started Jul 2011; status: terminated.

02

Drugs

zoledronic acid
03

Conditions

arterial calcificationarteriosclerosis

Beyond the preview

Go deeper on 2010-019656-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019656-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call